REAL-WORLD OUTCOME IN THE PRE-CAR-T ERA OF MYELOMA PATIENTS QUALIFYING FOR CAR-T CELL THERAPY: Real-world Assessment of Myeloma Patients as Candidates for CAR-T Therapy. (2020). Mediterranean Journal of Hematology and Infectious Diseases, 13(1), e2021012. https://doi.org/10.4084/mjhid.2021.012